Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Oct 21 EFFECT Notice of effectiveness
- 15 Oct 21 POS AM Prospectus update (post-effective amendment)
- 12 Apr 21 424B4 Prospectus supplement with pricing info
- 9 Apr 21 EFFECT Notice of effectiveness
-
8 Apr 21 POS AM Prospectus update (post-effective amendment)
- 15 Mar 21 424B7 Prospectus with selling stockholder info
- 15 Mar 21 EFFECT Notice of effectiveness
- 11 Mar 21 F-1/A Registration statement (foreign) (amended)
- 8 Mar 21 F-1 Registration statement (foreign)
SLN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form F-1 of Silence Therapeutics plc of our report dated March 30, 2021 relating to the financial statements of Silence Therapeutics plc, which appears in this registration statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Cambridge, United Kingdom
April 8, 2021